🎉 M&A multiples are live!
Check it out!

Curaleaf Valuation Multiples

Discover revenue and EBITDA valuation multiples for Curaleaf and similar public comparables like Grown Rogue, Cresco Labs, and Ayr Wellness.

Curaleaf Overview

About Curaleaf

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.


Founded

2014

HQ

Canada
Employees

5.5K+

Website

curaleaf.com

Financials

LTM Revenue $1.8B

LTM EBITDA $389M

EV

$2.9B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Curaleaf Financials

As of September 2025, Curaleaf reported last 12-month revenue of $1.8B and EBITDA of $389M.

In the same period, Curaleaf generated $891M in LTM gross profit and -$286M in net income.

See Curaleaf valuation multiples based on analyst estimates

Curaleaf P&L

In the most recent fiscal year, Curaleaf reported revenue of $956M and EBITDA of $166M.

Curaleaf expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Curaleaf valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $1.8B XXX $956M XXX XXX XXX
Gross Profit $891M XXX $455M XXX XXX XXX
Gross Margin 49% XXX 48% XXX XXX XXX
EBITDA $389M XXX $166M XXX XXX XXX
EBITDA Margin 21% XXX 17% XXX XXX XXX
EBIT $40.1M XXX $14.4M XXX XXX XXX
EBIT Margin 2% XXX 2% XXX XXX XXX
Net Profit -$286M XXX -$153M XXX XXX XXX
Net Margin -16% XXX -16% XXX XXX XXX
Net Debt XXX XXX $339M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Curaleaf Stock Performance

Curaleaf has current market cap of CAD 3.1B (or $2.2B), and EV of CAD 4.1B (or $2.9B).

Market Cap Evolution

Curaleaf Stock Data

As of October 17, 2025, Curaleaf's stock price is CAD 4 (or $3).

See Curaleaf trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.9B $2.2B XXX XXX XXX XXX $-0.27

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Curaleaf Valuation Multiples

Curaleaf's trades at 3.1x EV/Revenue multiple, and 17.6x EV/EBITDA.

See valuation multiples for Curaleaf and 15K+ public comps

Curaleaf Financial Valuation Multiples

As of October 17, 2025, Curaleaf has market cap of $2.2B and EV of $2.9B.

Equity research analysts estimate Curaleaf's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Curaleaf has a P/E ratio of -10.8x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $2.2B XXX $2.2B XXX XXX XXX
EV (current) $2.9B XXX $2.9B XXX XXX XXX
EV/Revenue 2.3x XXX 3.1x XXX XXX XXX
EV/EBITDA 10.6x XXX 17.6x XXX XXX XXX
EV/EBIT 102.7x XXX 203.7x XXX XXX XXX
EV/Gross Profit 4.6x XXX n/a XXX XXX XXX
P/E -10.8x XXX -14.3x XXX XXX XXX
EV/FCF 35.6x XXX 63.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Curaleaf Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Curaleaf Margins & Growth Rates

Curaleaf's last 12 month revenue growth is 3%

Curaleaf's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Curaleaf's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Curaleaf's rule of X is 30% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Curaleaf and other 15K+ public comps

Curaleaf Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 3% XXX 19% XXX XXX XXX
EBITDA Margin 21% XXX 17% XXX XXX XXX
EBITDA Growth 11% XXX 42% XXX XXX XXX
Rule of 40 17% XXX 21% XXX XXX XXX
Bessemer Rule of X XXX XXX 30% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 4% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 46% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Curaleaf Public Comps

See public comps and valuation multiples for Cannabis comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Ascend Wellness Holdings XXX XXX XXX XXX XXX XXX
Ayr Wellness XXX XXX XXX XXX XXX XXX
Cresco Labs XXX XXX XXX XXX XXX XXX
Grown Rogue XXX XXX XXX XXX XXX XXX
Green Thumb Indus XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Curaleaf M&A and Investment Activity

Curaleaf acquired  XXX companies to date.

Last acquisition by Curaleaf was  XXXXXXXX, XXXXX XXXXX XXXXXX . Curaleaf acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Curaleaf

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Curaleaf

When was Curaleaf founded? Curaleaf was founded in 2014.
Where is Curaleaf headquartered? Curaleaf is headquartered in Canada.
How many employees does Curaleaf have? As of today, Curaleaf has 5.5K+ employees.
Who is the CEO of Curaleaf? Curaleaf's CEO is Mr. Boris Jordan.
Is Curaleaf publicy listed? Yes, Curaleaf is a public company listed on TSE.
What is the stock symbol of Curaleaf? Curaleaf trades under CURA ticker.
When did Curaleaf go public? Curaleaf went public in 2015.
Who are competitors of Curaleaf? Similar companies to Curaleaf include e.g. Ascend Wellness Holdings, Ayr Wellness, Cresco Labs, Grown Rogue.
What is the current market cap of Curaleaf? Curaleaf's current market cap is $2.2B
What is the current revenue of Curaleaf? Curaleaf's last 12 months revenue is $1.8B.
What is the current revenue growth of Curaleaf? Curaleaf revenue growth (NTM/LTM) is 3%.
What is the current EV/Revenue multiple of Curaleaf? Current revenue multiple of Curaleaf is 2.3x.
Is Curaleaf profitable? Yes, Curaleaf is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Curaleaf? Curaleaf's last 12 months EBITDA is $389M.
What is Curaleaf's EBITDA margin? Curaleaf's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Curaleaf? Current EBITDA multiple of Curaleaf is 10.6x.
What is the current FCF of Curaleaf? Curaleaf's last 12 months FCF is $115M.
What is Curaleaf's FCF margin? Curaleaf's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Curaleaf? Current FCF multiple of Curaleaf is 35.6x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.